Synthesizing data and models for the spread of MERS-CoV, 2013: Key role of index cases and hospital transmission

Epidemics

Volumn 9, Issue , 2014, Pages 40-51

  Chowell, Gerardo ^a,b   Blumberg, Seth ^a,c   Simonsen, Lone ^a,d   Miller, Mark A ^a   Viboud, Cécile ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Community; Epidemic modeling; Hospital; Index cases; Middle east respiratory syndrome; Reproduction number

Indexed keywords

COMMUNITY; CORONAVIRUS; CORONAVIRUS INFECTION; DATA ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; EPIDEMIC; HOSPITAL; HOSPITAL PATIENT; HUMAN; INFECTION RISK; MATHEMATICAL MODEL; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; NONHUMAN; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION; ZOONOSIS; BIOLOGICAL MODEL; COMMUNITY-ACQUIRED INFECTIONS; CORONAVIRUS INFECTIONS; CROSS INFECTION; OBSERVER VARIATION; PHYSIOLOGY; TRANSMISSION; VIROLOGY;

COMMUNITY-ACQUIRED INFECTIONS; CORONAVIRUS INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, BIOLOGICAL; OBSERVER VARIATION;

EID: 84908692878     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.09.011     Document Type: Article

References (52)

1. Aburizaiza A.S., Mattes F.M., Azhar E.I., Hassan A.M., Memish Z.A., et al. Investigation of anti-MERS-Coronavirus antibodies in blood donors and abbatoir workers in Jeddah and Makkah, Kingdom of Saudi Arabia, fall 2012. J. Infect. Dis. 2013, 209(2):243-246. http://dx.doi.org/10.1093/infdis/jit589.
2. Alagaili A.N., Briese T., Mishra N., Kapoor V., Sameroff S.C., et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 2014, 5(2). e00884-14. http://dx.doi.org/10.1128/mBio.00884-14
3. Anderson R.M., May R.M. Infectious Diseases of Humans 1991, Oxford University Press, Oxford.
4. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013, 369:407-416.
5. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013, 13:752-761.
6. Blumberg S., Lloyd-Smith J.O. Inference of R(0) and transmission heterogeneity from the size distribution of stuttering chains. PLoS Comput. Biol. 2013, 9:e1002993.
7. 0 from the size distribution of subcritical transmission chains. Epidemics 2013, 5:131-145.
8. Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
9. Cauchemez S., Fraser C., Van Kerkhove M.D., Donnelly C.A., Riley S., et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect. Dis. 2014, 14:50-56.
10. Chowell G., Fenimore P.W., Castillo-Garsow M.A., Castillo-Chavez C. SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J. Theor. Biol. 2003, 224:1-8.
11. Chowell G., Castillo-Chavez C., Fenimore P.W., Kribs-Zaleta C.M., Arriola L., et al. Model parameters and outbreak control for SARS. Emerg. Infect. Dis. 2004, 10:1258-1263.
12. Chowell G., Ammon C.E., Hengartner N.W., Hyman J.M. Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland. Vaccine 2006, 24:6747-6750.
13. Chowell G., Simonsen L., Towers S., Miller M.A., Viboud C. Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med. 2013, 11:214.
14. Chu D.K.W., Poon L.L.M., Gomaa M.M., Shehata M.M., Perera R.A.P.M., et al. MERS coronaviruses in dromedary camels, Egypt. Emerg. Infect. Dis. 2014, 20(6):1049-1053. http://dx.doi.org/10.3201/eid2006.140299.
15. Cotten M., Watson S.J., Kellam P., Al-Rabeeah A.A., Makhdoom H.Q., et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013, 382:1993-2002.
16. de Wit E., Rasmussen A.L., Falzarano D., Bushmaker T., Feldmann F., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:16598-16603.
17. Diekmann O., Heesterbeek J. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation 2000, Wiley, Chichester.
18. Donnelly C.A., Ghani A.C., Leung G.M., Hedley A.J., Fraser C., et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003, 361:1761-1766.
19. Farrington C.P., Kanaan M.N., Gay N.J. Branching process models for surveillance of infectious diseases controlled by mass vaccination. Biostatistics 2003, 4:279-295.
20. Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D. Smallpox and its Eradication 1988, World Health Organization, Geneva.
21. Ferguson N.M., Fraser C., Donnelly C.A., Ghani A.C., Anderson R.M. Public health. Public health risk from the avian H5N1 influenza epidemic. Science 2004, 304:968-969.
22. Franks T.J., Chong P.Y., Chui P., Galvin J.R., Lourens R.M., et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum. Pathol. 2003, 34:743-748.
23. Evaluating the Accuracy of Sampling-based Approaches to Calculating Posterior Moments 1992, Oxford University Press, Oxford. J. Geweke (Ed.).
24. Gumel A.B., Ruan S., Day T., Watmough J., Brauer F., et al. Modelling strategies for controlling SARS outbreaks. Proc. Biol. Sci. 2004, 271:2223-2232.
25. Gustafsson L., Sternad M. Bringing consistency to simulation of population models-Poisson simulation as a bridge between micro and macro simulation. Math. Biosci. 2007, 209:361-385.
26. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2014, 14:140-145.
27. Haario H., Laine M., Mira A., Saksman E. DRAM: efficient adaptive MCMC. Stat. Comput. 2006, 16:339-354.
28. Harris T. The Theory of Branching Processes 2002, Dover, Toronto.
29. Ithete N.L., Stoffberg S., Corman V.M., Cottontail V.M., Richards L.R., et al. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis. 2013, 19:1697-1699.
30. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348:1953-1966.
31. Lange K. Applied Probability 2010, Springer, New York. second ed.
32. Lau J.T., Yang X., Leung P.C., Chan L., Wong E., et al. SARS in three categories of hospital workers, Hong Kong. Emerg. Infect. Dis. 2004, 10:1399-1404.
33. Lee N., Hui D., Wu A., Chan P., Cameron P., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003, 348:1986-1994.
34. Lessler J., Reich N.G., Brookmeyer R., Perl T.M., Nelson K.E., et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect. Dis. 2009, 9:291-300.
35. Leung G.M., Lim W.W., Ho L.M., Lam T.H., Ghani A.C., et al. Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol. Infect. 2006, 134:211-221.
36. Lipsitch M., Cohen T., Cooper B., Robins J.M., Ma S., et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003, 300:1966-1970.
37. Lloyd-Smith J.O., George D., Pepin K.M., Pitzer V.E., Pulliam J.R., et al. Epidemic dynamics at the human-animal interface. Science 2009, 326:1362-1367.
38. Memish Z.A., Al-Tawfiq J.A., Makhdoom H.Q., Al-Rabeeah A.A., Assiri A., et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their health Care worker and family contacts: a prospective descriptive study. Clin. Microbiol. Infect. 2014, 20(5):469-474. http://dx.doi.org/10.1111/1469-0691.12562.
39. Penttinen P., Kaasik-Aaslav K., Friaux A., Donachie A., Sudre B., et al. Taking stock of the first 133 MERS coronavirus cases globally-is the epidemic changing?. Euro. Surveill. 2013, 18(39). PII: 20596.
40. Rambaut A. MERS-cov Spatial, Temporal and Epidemiological Information 2013, Available from (http://epidemic.bio.ed.ac.uk/coronavirus_background) (last accessed on 11/15/2013).
41. Reusken C.B., Haagmans B.L., Muller M.A., Gutierrez C., Godeke G.J., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 2013, 13:859-866.
42. Riley S., Fraser C., Donnelly C.A., Ghani A.C., Abu-Raddad L.J., et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003, 300:1961-1966.
43. Rimoin A.W., Mulembakani P.M., Johnston S.C., Lloyd Smith J.O., Kisalu N.K., et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA 2010, 107:16262-16267.
44. Seto W.H., Tsang D., Yung R.W., Ching T.Y., Ng T.K., et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003, 361:1519-1520.
45. Tambyah P.A., Singh K.S., Habib A.G. SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a non-SARS hospital in Singapore. BMJ 2003, 327:620.
46. The World Health Organization Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Update June, 2014, Available from (http://www.who.int/csr/disease/coronavirus_infections/archive_updates/en/) (accessed on 19 June 2014).
47. Tefanie Gierer H.H.-W., Albuali Waleed H., Bertram Stephanie, Al-Rubaish Abdullah M., Yousef Abdullah A., Al-Nafaie Awatif N., Al-Ali Amein K., Obeid Obeid E., Alkharsah Khaled R., Stefan Pöhlmann Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia. Emerg Infect Dis. 2013, 19(12):2034-2036. http://dx.doi.org/10.3201/eid1912.130701.
48. Varia M., Wilson S., Sarwal S., McGeer A., Gournis E., et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003, 169:285-292.
49. The WHO MERS-CoV Research Group State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr. Outbreaks 2013.
50. Wolfe N.D., Dunavan C.P., Diamond J. Origins of major human infectious diseases. Nature 2007, 447:279-283.
51. World Health Organization Revised Interim Case Definition for Reporting to WHO-Middle East respiratory syndrome Coronavirus (MERS-CoV) 2013, [Last access on February 13].
52. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367:1814-1820.